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ABSTRACT
Objective: The infection of high-risk human papillomavirus (HPV) genotypes, particularly HPV-16 and HPV-18, is known to cause cervical cancer 
(CC); however, aberrant DNA methylation of death-associated protein kinase (DAPK), a member of tumor suppressor gene family, are required for 
cervical tumorigenesis. The aim of our study was to evaluate the hypermethylation frequency of CpG belonged to DAPK promoter, in Vietnamese 
patients, as well as to study about the association between hypermethylation, and high-risk HPV infection leading to CC.
Methods: Methylation-specific-polymerase chain reaction (MSP) was performed to analyze methylation status from 109 liquid-based papanicolaous 
test samples, collected from local hospital and were identified whether HPV/or non-HPV, high-risk/low-risk HPV infection, then was confirmed by 
sequencing.
Results: In the case of high-risk HPV infection, the frequency of DAPK gene hypermethylation was 66.67% (24 of 36 cases). Meanwhile, low 
hypermethylation status was found in low-risk and non-HPV infection, counting for 12.0% (3 of 25 cases), 2.1% (1 of 48 cases), respectively. Significant 
association of DAPK hypermethylation with high-risk, low-risk, and non-HPV infection was observed (p<0.0001). The DAPK hypermethylation 
increased the possibility to CC in the case of high-risk HPV infected with high incidence: Odds ratio=34.5 (95% confidence interval [CI]=10.15-117.23, 
p<0.01), relative risk=12.2 (95% CI=4.56-32.42, p<0.01).
Conclusion: Based on those data, it suggested that MSP carried out on noninvasive samples will lead to potential method to screening, diagnosis and 
early diagnosis of cervical carcinoma in Vietnamese population.
Keywords: Cervical cancer, Hypermethylation, Methylation-specific-polymerase chain reaction, Death-associated protein kinase, Vietnamese 
population.
INTRODUCTION
Persistent infection with high-risk genotype of human papillomavirus 
(HPV) has been known to be associated with the cervical 
carcinogenesis [1-4]. Among high-risk HPV genotypes, HPV-16 and-
18, which is identified as the common high-risk HPV genotypes and 
being the key role for the majority of cervical cancer (CC), counting 
for approximately 70.0% [5-9]. In Vietnam, the prevalence of 
cervical infection with HPV-16 and/or-18 among women was ranged 
from 3.1% to 7.4% [10]. Notably, the infection of high-risk HPV 
genotypes is considered as not exclusive prerequisites for cervical 
carcinogenesis [11]. Additional genetic and epigenetic alterations 
are required for progression from precancerous disease to invasive 
cancer [8,12,13]. Among the putative molecular alterations involved 
in cervical carcinogenesis process, promoter hypermethylation, an 
important epigenetic modification, has long been found to be a major 
mechanism of inactivation of tumor suppressor genes (TSGs), which has 
been considered as an early epigenetic event in driving carcinogenesis 
of many human cancers, including cancer of cervix [14-16].
The death-associated protein kinase (DAPK), a member of TSG 
family, located at 9q21.33, was a calcium/calmodulin-dependent 
seurine/threonine kinase involved in multiple cellular signaling 
pathways that trigger cell survival, apoptosis, and autophagy [14-18]. 
DAPK has been proved as participating in interferon-γ, Fas, tumor 
necrosis factor-β, extracellular signal-regulated kinase, C-myc and 
E2F-induced apoptosis, which suggested that DAPK is a conjunction 
of all kinds of apoptosis signals [18,19]. DAPK promoter aberrant 
hypermethylation has been reported involving in many primary 
tumors, including cervical carcinoma [16,17]. In Vietnam, the studies 
revealed to evaluation of TSGs had been reported, but still limited. 
Given examples, in our previous studies, the significant association 
between the hypermethylation of many TSGs, including p16INK4α, 
BRCA1, Cyclin D2, GSTP1, and RASSF1A, and breast cancer were 
reported. However, notably, there is no data regarding DAPK promoter 
hypermethylation in Vietnamese, which is considered involving CC 
[20-22]. Therefore, the aim at this study is to evaluate the frequency of 
hypermethylation of CpG which is belonged to promoter of DAPK gene, 
in Vietnamese population, as well as, to study about the association 
between the epigenetic event, hypermethylation, and high-risk HPV 
infection leading to the cancer of cervix. It was also noted here is the 
usage of liquid-based papanicolaous test specimens (Pap), noninvasive 
materials, to develop noninvasive method for prognosis and early 
diagnosis of CC in Vietnamese patients based on DNA methylation-
specific-polymerase chain reaction (MSP).
METHODS
Ethics statement
We used anonymized routine specimen surplus to clinical 
requirements for assay validation, adhering to a governance 
framework agreed by and with a Medic Medical Center and Au Lac 
Clinic Laboratory ethics agreement relating to the use of specimen 
surplus to clinical needs.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Sample collection
A total of 109 liquid-based Pap test samples were archived and admitted 
from the Au Lac Clinic, Vietnam. For input confirmed, the detection of 
HPV was carried out using LightPoweriVA HPV genotype PCR-reverse 
dot blot Kit (Code: VA.A02-003E, Viet-A Corporation, Vietnam). As 
the results, all samples were divided into two groups: Negative HPV 
infection group, which consisted of 48 samples; and positive HPV 
infection group, in which composed of 36 high-risk HPV (HPV genotype 
16, 18 and other high-risk genotypes) infected samples and 25 low-risk 
HPV infected samples.
DNA isolation, bisulfite modification, MSP assay
A total of genomic DNA was isolated from Pap samples by phenol/
chloroform method. Then, DNA concentration of DNA was quantified 
by the absorbance at OD260 and OD280. The pure preparation of DNA 
with OD260/OD280 ratio values of 1.8-2.0 was used to the bisulfite DNA 
modification assay. The bisulfite modification was carried out with 
approximately 2 μg genomic DNA of each sample by DNA modification 
Kit (Epitect Kit, Qiagen). The final precipitate was eluted in a volume of 
20 μl for MSP assay.
MSP assay was carried out in a total of 15 μl containing 3 μl bisulfite-
modified template DNA, 0.75 unit iTaq DNA polymerase (Biorad). MSP 
reaction was subjected to initial incubation at 95°C for 5 minutes, 
followed by 40 cycles at 95°C for 30s, ×°C for 30s, 72oC for 30s, and 
72°C for 6 minutes for final incubation. (Note: X was the annealing 
temperature of each specific methylated or unmethylated primer to 
candidate gene). The sequences of primers and ×°C for each primer 
annealing were noted in Table 1. Each PCR product was directly loaded 
onto a 2.0% agarose gel, stained with ethidium bromide, and directly 
visualized under ultraviolet illumination. Then, MSP products were 
sequencing to confirm the specificity of primers, examine the efficiency 
of bisulfite modification, and the hypermethylation status of target 
gene.
Statistical analysis
Statistical analyses were performed using Medcalc® Version 12.7.0.0 
that used the Chi-square test for sample size. The correlation between 
methylation status and HPV infected status was examined using the 
Chi-squared test. The differences of methylation frequencies of DAPK 
among groups were considered statistically significant for p≤0.05. 
Moreover, the odds ratio (OR), relative risk (RR) with 95% confidence 
intervals (CI) were also evaluated.
RESULTS
Hypermethylation status of DAPK promoter
In this study, MSP method was applied in DAPK promoter methylation 
detection. According to Table 2, in general, it indicated that, in the group 
of high-risk HPV-infection, the methylation frequency was 66.67% (24 
of 46 cases) as significant higher than in two other groups, which were 
12.0% (3 of 25 cases) and 2.08% (1 of 48 cases) for low-risk HPV-
infected group and non-HPV infected group, respectively. Moreover, in 
high-risk HPV infected samples, the methylation frequency, counting 
for 66.67%, was higher than unmethylation frequency counting for 
33.33%. Conversely, the status of unmethylation in low-risk HPV or 
non-HPV infected group was higher than the methylation in both low-
risk HPV infected group and non-HPV-infected group. Comparison with 
previous studies, giving example, the frequency of DAPK methylation 
was rather higher than Leung et al. (2008), which was 56.08%, carried 
on cervical samples. Moreover, the MSP product of DAPK was also 
observed in the band of both 172, 176 lengths in case of methylation 
and unmethylation, respectively, shown in Fig. 1. Then, the results of 
MSP were confirmed by sequencing and shown in Fig. 2. Concerning to 
the analysis of MSP product, shown in Figs. 1 and 2, we found that there 
was only one band with the length of 172 bps (in the case of methylated 
samples), and 176 bps (in the case of unmethylated samples). Then, 
MSP product was confirmed by MSP sequencing, according to Fig. 2, 
we successfully carried the bisulfite modification and MSP assay. 
By sequencing, making the comparison between the non-bisulfite 
modified (Fig. 2a) and bisulfite modified (Fig. 2b), all methylated 
cytosines were unchanged, which were marked as green characters. 
Otherwise, all the unmethylated cytosines were totally changed into 
thymine in bisulfite sequence. In addition, four methylated CpG sites 
were observed in methylated reverse primer, which was according to 
the primer designed. As shown in Fig. 2c and d, the signals of peaks 
in MSP product sequencing were quite good for reading nucleotide 
sequencing. Therefore, for those reasons, it was concluded that the 
bisulfite modification was successfully carried out.
Calculation of OR and RR
In this study, through the analysis of methylation or unmethylation 
status of DAPK, OR, RR was also calculated. The OR and RR were 
evaluation between high-risk HPV infection group and low-risk HPV 
group combined with non-HPV group, the OR and RR were 34.5 
(95% CI=10.15-117.23, p<0.01), 12.2 (95% CI=4.56-32.42, p<0.01), 
respectively.
DISCUSSION
In addition to HPV infection, particularly high-risk HPV genotypes, 
recently, the inactivation of TSGs due to promoter hypermethylation 
has been reported that it is a frequent mechanism plays an important 
criterion in cervical carcinogenesis [8,14-16]. In this study, we 
demonstrated that the hypermethylation of the DAPK gene promoter was 
found in high frequency in high-risk HPV infected samples, counting for 
66.67% (24 of 36 samples), compared to low-risk HPV infected samples, 
counting for 12.0% (3 of 25 samples) and non-HPV infected samples, 
counting for 2.08% (1of 48 samples). In the previous study, DAPK, a 
proapoptotic serine/threonine kinase, has been postulated to function 
as TSGs, plays a role in tumor pathogenesis and metastasis [18,19]. 
The inactivation of DAPK, mainly by promoter hypermethylation, has 
been reported in CC. Notably, promoter hypermethylation of DAPK 
was investigated and found to be significant higher in high-risk HPV 
infected samples than low-risk HPV infected samples and non-HPV 
infected samples (p<0.0001). It is thought that some Oncogenic viruses 
are known to interact with, and to modulate the expression of DNA 
methyltransferases (DNMTs), resulting to in the transactivation and 
transrepression of both cellular and viral genes [23,24]. Even though 
the relationship between HPV and aberrant methylation in CC is not 
well understood, some reports suggested E6 and E7 oncoprotein 
of high-risk HPV increase the expression and activity of DNMT1, 
which is the major mammalian enzyme responsible for maintaining 
CpG methylation patterns in the cell following replication, through 
the suppression of TSG p53 [25,26]. In addition, HPV-16 E7 bind to 
DNMT1 and precipitate, upregulate DNA methyltransferase activity, 
increased the hypermethylation in many TSGs led to the development 
Fig. 1: Methylated promoter of death-associated protein kinase 
gene was analyzed on some clinical samples by methylation-
specific-polymerase chain reaction (MSP). The MSP product was 
172/176 bps in length. (1 and 2) low-risk human papillomavirus 
(HPV) infected; (3-5): Non-HPV infected, (6-9): High-risk HPV 
infected samples, MW: Molecular weight marker, 100 bp; 
NC: Negative control
Table 1: Primer sequences were used in this study
Primer name Primer sequence (5’-3’) X°C P
DAPK-MF GGATAGTCGGATCGAGTTAACGTC 57 172
DAPK-MR CATAAACGCCAACGCCGAAAA
DAPK-UF GGAGGATAGTTGGATTGAGTTAATGTT 53 176
DAPK-UF CCATAAACACCAACACCAAAAA
Note:CpG islands were bold and underlined, X°C: Primer annealing 
temperature, M: Methylated, U: Unmethylated, F: Forward, R: Reverse, P: 
Product size, DAPK: Death-associated protein kinase
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of human cancer of cervix [22]. In this study, the hypermethylation 
of DAPK promoter was detectable in liquid-based Pap test sample by 
MSP method. The advantage of using Pap test samples is one kind of 
noninvasive samples, contains exfoliating cells from the transformation 
zone of the cervix; thus, the presence of DNA in exfoliating cells 
has offered an opportunity to find out the predictive and diagnosis 
biomarkers for CC [27-29]. In addition, MSP method is the simple, rapid 
and inexpensive method that determine the methylation status of CpG 
islands. Extraordinary the sensitivity of 0.1% can be achieved in MSP 
with a low false positive rate [18,30]. Moreover, MSP method shows an 
advantage in the requirement of only small quantities of DNA and could 
be applied on DNA extracted from noninvasive samples [30].
The hypermethylation of DAPK in cervical patients was significantly 
associated with an approximately 34.5-fold increase in the high-
risk HPV infected group than compared to low-risk and/or non-HPV 
infected group (OR=34.5, 95% CI=10.15-117.23, p<0.01). Concerning 
to RR value, it indicated that high-risk HPV infection significantly 
increased 12.2 times in the risk of DAPK hypermethylation, leading 
to the inactivation of DAPK (RR=3.31, 95% CI=1.75-6.26, p<0.01), 
compared to without DAPK promoter hypermethylation.
These observations open up to the possibility that the association 
between the DAPK promoter hypermethylation and high-risk HPV 
infection will offer the potential method, which based on MSP method 
carried out in noninvasive samples, for screening, predictive and 
diagnosis biomarkers for human CC in Vietnamese population.
CONCLUSION
In summary, hypermethylation of CpG islands within the promoter 
region of DAPK, which frequency was counting for 66.67%, 12.0%, 
2.1% for high-risk, low-risk and non-HPV infection, respectively, is 
a feature of human cancer of cervix, involving in the HPV infection in 
Vietnamese population. Moreover, the OR and RR were found in the 
high value, counting for 34.5 and 12.2, respectively. Consequently, we 
propose that the screening, which based on the combination of both 
high-risk HPV detection and DAPK gene’s promoter methylation, will 
be an auspicious characteristic for early predictive and diagnosis of CC.
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